<p>Fever of Unknown Origin (FUO) remains a diagnostic challenge, defined by prolonged fever lasting for more than three weeks without a clear cause despite a minimum of three days of hospital investigations or three outpatient visits at least. This study aims to explore the etiologies and potential predictive factors for classic FUO in Italy, updating prior data from earlier studies. Conducted from October 2019 to June 2023, this prospective, multi-center registry enrolled 188 patients from 25 Italian hospitals, assessing demographics, comorbidities, and clinical characteristics in relation to FUO causes. Results indicated that 72.1% of cases reached a final diagnosis, with etiologies primarily in non-infectious inflammatory (31.8%), infectious (25.7%), and neoplastic (8.4%) categories, while 27.9% remained undiagnosed. Younger patients (under 55&#xa0;years) were more likely to lack a definitive diagnosis, suggesting that advanced investigations might benefit early this patient population. Comorbid conditions like chronic obstructive pulmonary disease and cardiovascular symptoms were associated with infectious causes, whereas musculoskeletal and dermatologic signs suggested a non-infectious inflammatory origin. The overall mortality rate was 2.8% at a 6-month follow-up. This study highlights the need for improved diagnostic tools to address the substantial number of undiagnosed FUO cases. Trial registration: NCT05254522 ClinicalTrials.gov identifier.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Fever of unknown origin (FUO) FADOI-SIMIT Italian registry: can demographics, comorbidities, and clinical variables predict the etiology of classic FUO?—a prospective Italian study

  • Roberto Luzzati,
  • Verena Zerbato,
  • Luciano Attard,
  • Giulio Virgili,
  • Alessandro Cilli,
  • Ada Zanier,
  • Marco Libanore,
  • Daniela Segala,
  • Andrea Tedesco,
  • Maria Elena Bortolotti,
  • Emanuele Pontali,
  • Marcello Feasi,
  • Azzurra Re,
  • Igor Giarretta,
  • Fulvio Pomero,
  • Elisa Zagarrì,
  • Ercole Concia,
  • Francesco Dentali,
  • Dario Manfellotto,
  • Mauro Campanini,
  • Luciano Attard,
  • Giulio Virgili,
  • Alessandro Cilli,
  • Silvia Cretella,
  • Matteo Bassetti,
  • Daniele Roberto Giacobbe,
  • Laura Labate,
  • Monica Melchio,
  • Francesca Brillo,
  • Bruno Cacopardo,
  • Federica Cosentino,
  • Andrea Marino,
  • Mauro Campanini,
  • Azzurra Re,
  • Antonio Cascio,
  • Raffaella Rubino,
  • Antonella Castagna,
  • Anna Danise,
  • Francesco Castelli,
  • Alberto Bergamasco,
  • Giovanni Moioli,
  • Michela Conti,
  • Amina Zaffagnini,
  • Rossella Dionisio,
  • Luigi Castello,
  • Pietro Luigi Garavelli,
  • Cecilia Costa,
  • Olivia Bargiacchi,
  • Paolo Antonio Grossi,
  • Cristina Rovelli,
  • Marco Libanore,
  • Daniela Segala,
  • Roberto Luzzati,
  • Verena Zerbato,
  • Dario Manfellotto,
  • Luca Dilazzaro,
  • Eleonora Moriconi,
  • Vinicio Manfrin,
  • Marta Mascarello,
  • Eleonora Nicolini,
  • Paola Sterpone,
  • Emanuele Pontali,
  • Marcello Feasi,
  • Giovanni Scanelli,
  • Lia Tinillero,
  • Fabrizio Taglietti,
  • Emanuela Caraffa,
  • Andrea Tedesco,
  • Moreno Tresoldi,
  • Raffaella Scotti,
  • Irene Vandoni,
  • Fabio Zanini,
  • Francesco Vitale,
  • Ada Zanier

摘要

Fever of Unknown Origin (FUO) remains a diagnostic challenge, defined by prolonged fever lasting for more than three weeks without a clear cause despite a minimum of three days of hospital investigations or three outpatient visits at least. This study aims to explore the etiologies and potential predictive factors for classic FUO in Italy, updating prior data from earlier studies. Conducted from October 2019 to June 2023, this prospective, multi-center registry enrolled 188 patients from 25 Italian hospitals, assessing demographics, comorbidities, and clinical characteristics in relation to FUO causes. Results indicated that 72.1% of cases reached a final diagnosis, with etiologies primarily in non-infectious inflammatory (31.8%), infectious (25.7%), and neoplastic (8.4%) categories, while 27.9% remained undiagnosed. Younger patients (under 55 years) were more likely to lack a definitive diagnosis, suggesting that advanced investigations might benefit early this patient population. Comorbid conditions like chronic obstructive pulmonary disease and cardiovascular symptoms were associated with infectious causes, whereas musculoskeletal and dermatologic signs suggested a non-infectious inflammatory origin. The overall mortality rate was 2.8% at a 6-month follow-up. This study highlights the need for improved diagnostic tools to address the substantial number of undiagnosed FUO cases. Trial registration: NCT05254522 ClinicalTrials.gov identifier.